相关实验视频
Updated: May 19, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
评论文章 - 医院中的糖尿病技术:最新情况
Margaretha M Visser1, Roman Vangoitsenhoven1, Pieter Gillard1
1Department of Endocrinology, University Hospitals Leuven, Louvain, Belgium.
Current diabetes reports
|June 6, 2024
概括
先进的糖尿病技术,如持续血糖监测 (CGM) 和自动胰岛素输送 (AID),显示出改善住院患者血糖控制的希望. 需要进一步的研究和克服实施障碍,才能在医院广泛采用.
科学领域:
- 内分泌学 在内分泌学.
- 医疗技术 医疗技术 医学技术
- 医院 医院 医疗 医疗 医疗 医疗
背景情况:
- 糖尿病技术如持续血糖监测 (CGM),胰岛素疗法 (CSII) 和自动胰岛素输送 (AID) 越来越多地用于门诊护理.
- 先进的糖尿病技术的住院使用受到后勤挑战和员工培训需求的限制.
- 由于饮食改变和压力诱导的高血糖症,医院环境对血糖控制提出了独特的挑战.
研究的目的:
- 审查最近关于糖尿病技术在医院环境中的应用的文献.
- 探索将先进的葡萄糖监测和胰岛素输送设备集成到医院中的潜力.
- 确定未来研究住院糖尿病技术的途径.
主要方法:
- 这是一个叙事评论.
- 该综述综合了医院环境中糖尿病技术的最新文献.
主要成果:
- 先进的糖尿病技术可以增强住院患者的血糖控制,包括患有和没有糖尿病的人.
- 持续血糖监测 (CGM) 提供了准确,患者友好的监测和治疗调整.
- 自动注射胰岛素 (AID) 系统可以改善血糖控制,减少护理工作量.
结论:
- 糖尿病技术具有改善住院糖尿病管理和降低发病率/死亡率的潜力.
- 在医院广泛实施之前,需要对疗效,准确性和安全性的进一步研究.
- 解决成本和人员培训等实施因素对于成功的整合至关重要.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...

